Mineralocorticoid receptor antagonists for every patient with heart failure
- PMID: 39232491
- DOI: 10.1016/S0140-6736(24)01755-0
Mineralocorticoid receptor antagonists for every patient with heart failure
Conflict of interest statement
FHR received payment from Novartis in 2022 for two educational presentations on heart failure. AG declares no competing interests.
Comment on
-
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.Lancet. 2024 Sep 21;404(10458):1119-1131. doi: 10.1016/S0140-6736(24)01733-1. Epub 2024 Sep 1. Lancet. 2024. PMID: 39232490
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
